Chemotherapy for advanced non-small cell lung cancer.
作者信息
Herbst R S, Dang N H, Skarin A T
机构信息
Department of Medical Oncology/STAMP, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
出版信息
Hematol Oncol Clin North Am. 1997 Jun;11(3):473-517. doi: 10.1016/s0889-8588(05)70445-7.
PMID:9209907
Abstract
Lung cancer is the most lethal cancer in both men and women. Given that chemotherapy for advanced disease is marginally beneficial and noncurative, its use must be governed judiciously, with each decision being evaluated individually for each patient. Chemotherapy for lung cancer has progressed over the past decade, and with the advent of new agents, its future looks promising.
摘要
Zotero 插件